Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
No fee travel credit cards come with key benefits that can enhance your travel experience. Learn what they are to make informed choices.
26,188 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Bank Of America boosts its Affirm Holdings target to $88 after a solid quarter, framing May 12 investor day as a cata...
As Zebra Technologies previews its Q1 2026 results, investors weigh hardware demand, software subscriptions, and marg...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
Figma trades higher ahead of tonight’s Q1 print, as analysts eye revenue growth and AI momentum. Live coverage tracks...
As investors seek clarity in a shifting media world, Newsmax’s Q1 2026 earnings offer clues about growth, profitabili...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
XRP trades in a tight band around $1.40 as traders weigh regulatory progress, ETF flows, and Bitcoin momentum. This r...
Bitcoin has moved sharply after its peak, creating a dilemma for investors. This guide breaks down what bitcoin after...
Investing in cosmetics often blends branding bias with numbers. This guide looks at whether e.l.f. beauty stock rhode...
This article offers a clear, original look at Champion Homes (SKY) 2026 earnings outlook. Learn the key drivers, what...
Investors are watching GameSquare closely as 2025 earnings unfold. This guide explains what to look for in the Q4 res...